NCT02403687View on ClinicalTrials.gov

Prospective Analgesic Compound Efficacy (PACE) Study

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions
ArthritisTendonitisGoutRadiculopathyMuscle SpasmsSynovitisMigraineHeadache
Interventions
DRUG

baclofen 2%

compound topical cream

DRUG

Bupivacaine hydrochloride 1%

compound topical cream

DRUG

Cyclobenzaprine hydrochloride 2%

compound topical cream

DRUG

Diclofenac Sodium 3%

compound topical cream

DRUG

Flurbiprofen 10%

compound topical cream

DRUG

Gabapentin 6%

compound topical cream

DRUG

Ketamine 10%

compound topical cream

DRUG

Lidocaine 2%

compound topical cream

DRUG

Prilocaine 2.5%

compound topical cream

DRUG

Meloxicam 0.09%

compound topical cream

DRUG

Sumatriptan 5%

compound topical cream

DRUG

Tizanidine 0.1%

compound topical cream

DRUG

Topiramate 2.5%

compound topical cream

DRUG

Capsaicin, USP 0.0375%

compound topical cream

DRUG

Menthol, NF 5.00 %

compound topical cream

All Listed Sponsors
lead

Express Specialty Pharmacy

OTHER

NCT02403687 - Prospective Analgesic Compound Efficacy (PACE) Study | Biotech Hunter | Biotech Hunter